- Supported exchanges /
- SHE /
- 000627.SHE
Hubei Biocause Pharmaceutical (000627 SHE) stock market data APIs
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.
Hubei Biocause Pharmaceutical Financial Data Overview
| 4.19 | |
| 4.26 | |
| - | |
| 4.3 | |
| 4.13 | |
| 1.61-4.95 | |
| 20 553 M | |
| 4 941 M | |
| 40 698 M | |
| 0.0065 | |
| 0.724 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Hubei Biocause Pharmaceutical Fundamental Data is available in our Financial Data APIs
- Net Revenue 40 698 M
- EBITDA -2 037 982 848
- Earnings Per Share -0.15
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Hubei Biocause Pharmaceutical Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Hubei Biocause Pharmaceutical End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
